Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19
Nils Kappelmann, Robert Dantzer, Golam M. Khandaker
Psychoneuroendocrinology (2021) Vol. 131, pp. 105295-105295
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
Maria Alice Freitas Queiroz, Pablo Fabiano Moura das Neves, Sandra Souza Lima, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 173
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 139
A review of cytokine-based pathophysiology of Long COVID symptoms
Russell N. Low, Ryan Low, Athena Akrami
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 92
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis
Jing-Xian Yin, Yannick Luther Agbana, Zhishan Sun, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 89
Neuropsychiatric aspects of long COVID: A comprehensive review
Takafumi Kubota, Naoto Kuroda, Daichi Sone
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 84-93
Open Access | Times Cited: 76
Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 62
The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis
Niloofar Seighali, Abolfazl Abdollahi, Arman Shafiee, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 40
Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene): A clinical study.
K. R. Rees, Rebecca Aicheler, Lee Butcher, et al.
Cytokine (2025) Vol. 189, pp. 156884-156884
Closed Access | Times Cited: 1
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Michael J. Peluso, Hannah M. Sans, Carrie A. Forman, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 65
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19
Jennifer Frontera, Naomi M. Simon
JAMA Psychiatry (2022) Vol. 79, Iss. 8, pp. 811-811
Open Access | Times Cited: 50
Long COVID, neuropsychiatric disorders, psychotropics, present and future
Siu Wa Tang, Brian E. Leonard, Daiga M. Helmeste
Acta Neuropsychiatrica (2022) Vol. 34, Iss. 3, pp. 109-126
Open Access | Times Cited: 44
Post-COVID-19 Condition: Where Are We Now?
Paula Boaventura, Sofia Macedo, Filipa M. Ribeiro, et al.
Life (2022) Vol. 12, Iss. 4, pp. 517-517
Open Access | Times Cited: 43
Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation
T. Küchler, Roman Günthner, Andrea Ribeiro, et al.
Angiogenesis (2023) Vol. 26, Iss. 4, pp. 547-563
Open Access | Times Cited: 26
Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions
César Fernández‐de‐las‐Peñas, Arkiath Veettil Raveendran, Rocco Giordano, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2959-2959
Open Access | Times Cited: 25
Inflammatory and Cardiac Biomarkers in Relation with Post-Acute COVID-19 and Mortality: What We Know after Successive Pandemic Waves
Cătălina Lionte, Victorița Șorodoc, Raluca Ecaterina Haliga, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 29
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up
Carla Gramaglia, E. Gattoni, Eleonora Gambaro, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 27
Cortical thickness alterations and systemic inflammation define long-COVID patients with cognitive impairment
Bianca Besteher, Tonia Rocktäschel, Alejandra P. Garza, et al.
Brain Behavior and Immunity (2023) Vol. 116, pp. 175-184
Open Access | Times Cited: 20
Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-Guided Diagnosis and Management
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Viruses (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 19
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 5
Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19
Michael Fleischer, Fabian Szepanowski, Anne K. Mausberg, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 5
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Análise in silico das proteínas e genes com potencial envolvimento nos transtornos depressivos e ansiosos nas condições pós-COVID
Flávio dos Santos Alvarenga, Aléxia Stefani Siqueira Zetum, Matheus Correia Casotti, et al.
Brazilian Journal of Health Review (2025) Vol. 8, Iss. 1, pp. e76715-e76715
Open Access
Cost‐effectiveness of plasmapheresis and hemoperfusion in COVID‐19 survivors: A six‐month follow‐up analysis after hospital discharge
Soroush Dianaty, Farshid Gholami, Hamid Reza Gholamrezaie, et al.
Therapeutic Apheresis and Dialysis (2025)
Closed Access
Fu Tu Sheng Jin Rehabilitation Formula Mitigate Airway Inflammation, Mucus Secretion and Immune Dysfunction Induced by SARS-CoV-2 Spike Protein
Bo-Han Wang, Keyao Yu, Xiaona Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 1053-1065
Open Access
Spatial transcriptomics of the epipharynx in long COVID identifies SARS-CoV-2 signalling pathways and the therapeutic potential of epipharyngeal abrasive therapy
Kensuke Nishi, Shohei Yoshimoto, Takayuki Tanaka, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top